UNSPSC 85818711: Transfusion of autologous plasma cryoprecipitate into central artery, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of autologous plasma cryoprecipitate into central artery, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30263M0

UNSPSC 85818711 Transfusion of autologous plasma cryoprecipitate into central artery, percutaneous approach is a Commodity code that shows little relevant recent activity. The six state and local opportunities posted under this code between July and September 2026 involve independent medical evaluation services, surgical benefit carve-outs, occupational medical surveillance, emergency and specialty healthcare for youth in custody, pharmacy benefit management, and temporary health professional staffing — none of which align with the code's nominal scope of transfusion procedures. The code appears to be a classification mismatch in the sourcing systems of the issuing bodies, and does not reflect genuine procurement of autologous plasma cryoprecipitate transfusion services by state or local governments.

No state or local government solicitations under this code are pursuing work aligned with its defined commodity scope. Procurement professionals evaluating activity under UNSPSC 85818711 should treat this code as inactive for state and local business development purposes and verify whether related medical procedure or blood product services are instead classified under alternative UNSPSC codes within the health services or clinical laboratory segment.